Effect of GJIC modulation on Jak2/STAT5 in mammary cells in vitro

被引：0
|
作者：
Talhouk, RS [1 ]
Ismail, A [1 ]
Zeytouni, T [1 ]
El-Sabban, ME [1 ]
机构：
[1] Amer Univ Beirut, Beirut, Lebanon
来源：
MOLECULAR BIOLOGY OF THE CELL | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
2765
引用
下载
收藏
页码：491A / 491A
页数：1
相关论文
共 50 条
  • [21] Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes
    McWhinney, CD
    Dostal, D
    Baker, K
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (04) : 751 - 761
  • [22] JAK2/STAT5 signaling in the lipopolysaccharide (LPS)-induced inhibition of osteoblast differentiation
    Wu, Hao
    Liu, Guanghui
    Yu, Bin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11119 - 11128
  • [23] Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
    Schwaller, J
    Parganas, E
    Wang, DM
    Cain, D
    Aster, JC
    Williams, IR
    Lee, CK
    Gerthner, R
    Kitamura, T
    Frantsve, J
    Anastasiadou, E
    Loh, ML
    Levy, DE
    Ihle, JN
    Gilliland, DG
    MOLECULAR CELL, 2000, 6 (03) : 693 - 704
  • [24] Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EPOR
    Grebien, F.
    Kerenyi, M. A.
    Kovacic, B.
    Kolbe, T.
    Klingmuller, U.
    Mueller, M.
    Beug, H.
    Moriggl, R.
    Mullner, E. W.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 106 - 106
  • [25] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
    Keller, Alexandra
    Wingelhofer, Bettina
    Peter, Barbara
    Bauer, Karin
    Berger, Daniela
    Gamperl, Susanne
    Reifinger, Martin
    Cerny-Reiterer, Sabine
    Moriggl, Richard
    Willmann, Michael
    Valent, Peter
    Hadzijusufovic, Emir
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : 55 - 68
  • [26] JAK2/STAT5 Pathway Mediates Prolactin-Induced Apoptosis of Lactotropes
    de Dios, Nataly
    Orrillo, Santiago
    Irizarri, Martin
    Susana Theas, Maria
    Boutillon, Florence
    Candolfi, Marianela
    Seilicovich, Adriana
    Goffin, Vincent
    Pisera, Daniel
    Ferraris, Jimena
    NEUROENDOCRINOLOGY, 2019, 108 (02) : 84 - 97
  • [27] Angiotensin II activates STAT5 through JAK2 kinase in rat kidney mesangial cells.
    Marrero, MB
    Venema, VJ
    Li, B
    Eaton, DC
    Venema, RC
    FASEB JOURNAL, 1999, 13 (04): : A365 - A365
  • [28] Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5
    Xiao, Meifang
    Zhang, Liming
    Zhou, Yizheng
    Rajoria, Pasupati
    Wang, Changfu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 469 (03) : 716 - 722
  • [29] Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
    Hexner, Elizabeth O.
    Serdikoff, Cynthia
    Jan, Mahfuza
    Swider, Cezary R.
    Robinson, Candy
    Yang, Shi
    Angeles, Thelma
    Emerson, Stephen G.
    Carroll, Martin
    Ruggeri, Bruce
    Dobrzanski, Pawel
    BLOOD, 2008, 111 (12) : 5663 - 5671
  • [30] Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis
    Caffarel, M. M.
    Zaragoza, R.
    Pensa, S.
    Li, J.
    Green, A. R.
    Watson, C. J.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (03): : 511 - 522
12345